Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHZD.L Regulatory News (HZD)

  • There is currently no data for HZD

Total Voting Rights

5 Apr 2018 07:00

RNS Number : 8682J
Horizon Discovery Group plc
05 April 2018
Β 

5 April 2018

Β 

Horizon Discovery Group plcΒ 

Β 

Total Voting Rights

Β 

In accordance with Disclosure and Transparency Rule 5.6.1 Horizon Discovery Group plc (the "Company") advises that:

Β 

As at 31 March 2018, the Company's issued share capital consisted of 149,091,182 ordinary shares of 1p each with voting rights. The Company does not hold any ordinary shares in Treasury.

Β 

The total number of voting rights in the Company is therefore 149,091,182.

Β 

The above figure (149,091,182) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Horizon Discovery Group plc under the FCA's Disclosure and Transparency Rules.

Β 

ENDS

Β 

For further information, please contact:

Β 

Horizon Discovery Group plc

Richard Vellacott, Interim Chief Executive Officer

Chris Claxton, VP Investor Relations

Tel: +44 (0) 1223 655 580

Β 

Numis Securities Limited (Broker and NOMAD)

Michael Meade / Freddie Barnfield

Tel: +44 (0)Β 207 260 1000

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TVRUGURPCUPRGQC
Date   Source Headline
26th Jan 20187:00 amRNSBlock Listing Six Monthly Return
18th Dec 20177:00 amRNSAgreement with Roche Diagnostics
5th Dec 20177:00 amRNSHZD expand CRISPR license rights with ERS Genomics
24th Nov 20172:54 pmRNSTotal Voting Rights
3rd Oct 20172:10 pmRNSTotal Voting Rights
26th Sep 20177:00 amRNSInterim Results
25th Sep 20173:35 pmRNSHoldings in Company
8th Sep 20177:00 amRNSTrading Update
4th Sep 20173:42 pmRNSHolding(s) in Company
4th Sep 20172:37 pmRNSHolding(s) in Company
31st Aug 20173:30 pmRNSCompletion of Acquisition
24th Aug 20173:56 pmRNSHolding(s) in Company
24th Aug 20173:29 pmRNSHolding(s) in Company
23rd Aug 20178:18 amRNSCompletion of Placing
22nd Aug 20172:12 pmRNSUpdate on Acquisition of GE Healthcare Dharmacon
7th Aug 201710:19 amRNSResult of General Meeting
7th Aug 20177:00 amRNSDirector/PDMR Shareholding
24th Jul 20177:00 amRNSBlock Listing Application
19th Jul 20177:00 amRNSAcquisition and Proposed Placing to Raise £80m
7th Jul 20177:00 amRNSAdditional Listing
4th Jul 20171:55 pmRNSHoldings in Company
3rd Jul 20177:00 amRNSReference Standards support successful FDA filing
28th Jun 201710:57 amRNSResult of AGM
26th Jun 20171:54 pmRNSHolding(s) in Company
16th Jun 20177:00 amRNSAdditional Listing
6th Jun 20177:00 amRNSAdditional Listing
2nd Jun 20177:00 amRNSAnnual Report and Notice of Annual General Meeting
31st May 20177:00 amRNSAdditional Listing
30th May 20177:00 amRNSPreliminary Results Year Ended 31 December 2016
22nd May 20177:00 amRNSHZD Licenses New Gene Editing Technology Platform
9th May 20177:00 amRNSPerformance update in Immuno-Oncology
21st Apr 20177:00 amRNSAdditional Listing
19th Apr 20177:00 amRNSNotice of Results
11th Apr 20172:57 pmRNSHoldings in Company
7th Apr 20175:01 pmRNSGrant of Options
6th Apr 20177:00 amRNSAdditional Listing
30th Mar 20179:08 amRNSHoldings in Company
24th Mar 20177:00 amRNSAdditional Listing
23rd Mar 201711:24 amRNSHoldings in Company
20th Mar 201710:42 amRNSHoldings in Company
14th Mar 20177:00 amRNSAgreement for NIPT Reference Standards
23rd Feb 20177:00 amRNSSite Visit
20th Feb 20171:21 pmRNSHolding(s) in Company
15th Feb 20177:00 amRNSAdditional Listing
14th Feb 20177:00 amRNSMaster Service Agreement with Top 3 Pharma Company
10th Feb 20177:00 amRNSAdditional Listing
31st Jan 20173:06 pmRNSHolding(s) in Company
31st Jan 20177:00 amRNSIssue of Equity
26th Jan 20171:50 pmRNSHolding(s) in Company
24th Jan 20177:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.